Imagen de Portada

Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	Mamoor, Shahan
Formato:	Recurso digital
Publicado:	Zenodo 2026
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

TSC22D4 gene activation in Crohn's Disease.
por: Mamoor, Shahan
Publicado: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
por: Mamoor, Shahan
Publicado: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
por: Mamoor, Shahan
Publicado: (2025)

Adirf activation in chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

Ep300 activation defines a common epigenetic route in chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

NLRP7 engagement in transformation and etiology of chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

Genes that function in axon guidance are associated with disease progression in breast and lung cancer.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
por: Mamoor, Shahan
Publicado: (2025)

LOC107984343, a TE differentiation-associated product.
por: Mamoor, Shahan
Publicado: (2026)

NLRC4 regulates a unique immunologic program.
por: Mamoor, Shahan
Publicado: (2025)

Aire is a component gene of the Th17 gene signature.
por: Mamoor, Shahan
Publicado: (2025)

Haglr, a HOXD antisense growth-associated long non-coding RNA with functions in lineage commitment in the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
por: Mamoor, Shahan
Publicado: (2025)

Androgen signaling has functions in lineage commitment in the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

Unbiased discovery of genes required for pluripotency: Terf1.
por: Mamoor, Shahan
Publicado: (2026)

Major differences between HPV+ and HPV- head and neck cancer.
por: Mamoor, Shahan
Publicado: (2026)

Disparate immune receptor control by p53 sufficient and p53 deficient cancers.
por: Mamoor, Shahan
Publicado: (2026)

An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
por: Mamoor, Shahan
Publicado: (2026)

An expression screen to identify genes important for trastuzumab resistance: Ccl19.
por: Mamoor, Shahan
Publicado: (2026)

Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
por: Mamoor, Shahan
Publicado: (2026)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
por: Mamoor, Shahan
Publicado: (2026)

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
por: Mamoor, Shahan
Publicado: (2026)